Table 2.
Outcomes and Complications |
BTX
(n = 24) |
Placebo
(n = 22) |
P
value |
---|---|---|---|
Number of index abdominal procedures | 2 (1-3) | 2.0 (1-3) | .14 |
Number of days of open abdomen | 5.0 (2.0-6.5) | 2.0 (2.0-5.0) | .15 |
Duration of hospital stay | 23.5 (13.5-36.5) | 19.0 (11.0-23.0) | .19 |
ICU Duration of stay (median) | 8.0 (4.0-25.0) | 6.0 (3.0-13.5) | .32 |
Ventilator days | 3.0 (1.0-9.0) | 4.0 (1.0-9.0) | .44 |
30 day mortality | 0 (0) | 2 (9) | .22 |
Wound infection | 2 (8) | 0(0) | >.99 |
Intraabdominal abscess | 1 (4) | 1 (5) | >.99 |
Anastomotic leak | 1 (4) | 0 (0) | >.99 |
Dehiscence | 2 (8) | 0 (0) | .49 |
Enterocutaneous fistula | 1 (4) | 1 (5) | >0.99 |
Bleeding | 5 (21) | 4 (18) | >.99 |
Reoperation after closure | 0 (0) | 1 (5) | .48 |
Acute renal failure | 6 (25) | 7 (32) | .75 |
ICU – intensive care unit